High Intensity Interval Training in 1% or 10% Slope (Slope)

July 27, 2015 updated by: Alberto Souza de Sá Filho, Universidade Federal do Rio de Janeiro

Effect of Six Running Sessions of High Intensity Interval Training in Different Slopes on Aerobic Performance: a Randomized Controlled Trial

The objective was to determine the effect of six running sessions of high intensity interval training (HIIT) at 1% and 10% incline on VO2max, peak of velocity (VPeak), and time limit of 1% (TLim1%) and 10% (TLim10%) of inclination, as well as the influence of the specificity of training on performance in the different inclines.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Our study is assuming greater activation / muscle overload coming from the uphill running. Accordingly, we believe that in a parallel-group design (1% or 10% gradient) established in controlled and randomized way we could answer the hypothesis that muscle overload provide superior gains to VO2max and aerobic performance. Moreover, considering the first hyphotesis, such developments on the running at 10% slope also promote significant gains in climb performance and also in the plan. Unlike the speculate that the gains from the 1% training does not help performance a 10% incline.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Minimum standards of physical activity proposed by the ACSM
  • Perform running activity at high intensities (HIT)

Exclusion Criteria:

  • No cardiovascular problems, respiratory or metabolic
  • No muscle or joint injuries
  • Not to use drugs or ergogenic resources

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interval Training at 1% incline
Six Sessions of High Intensity Interval Running (100% VO2Max) at 1% incline; Group metabolically balanced.
Behavioral: Interval Training at 1% Incline
Six Sessions of Running at 1% incline
Other Names:
  • HIT in 1% Slope
  • HIIT in 1% Slope
Experimental: Interval Training at 10% incline
Six Sessions of High Intensity Interval Running (100% VO2Max) at 10% incline; Group metabolically balanced.
Behavioral: Interval Training at 10% Incline
Six Sessions of Running at 10% incline
Other Names:
  • HIT in 10% Slope
  • HIIT in 10% Slope
No Intervention: Control
Only Dependent Variables Measures

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal oxygen uptake (VO2Max)
Time Frame: 0 week - 3 week (2 sessions for week)
VO2Max measured in baseline and after training
0 week - 3 week (2 sessions for week)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to Exhaustion (TLim 1% and 10%)
Time Frame: 0 week - 3 week (2 sessions for week)
TLim1% and TLim10% Metabolically balanced (ACSM equation) measured in baseline and after training
0 week - 3 week (2 sessions for week)
Transfer of performance gains of TLim1% and TLim10% slope
Time Frame: 0 week - 3 week (2 sessions for week)
Transfer of performance gains in TLim 1% and 10% slope
0 week - 3 week (2 sessions for week)
Peak Velocity
Time Frame: 0 week - 3 week (2 sessions for week)
Performance in Progressive Test
0 week - 3 week (2 sessions for week)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidade Federal do Rio de Janeiro

Investigators

  • Study Director: Sérgio Machado, PhD, Universidade Federal do Rio de Janeiro

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

August 1, 2013

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

July 11, 2015

First Submitted That Met QC Criteria

July 27, 2015

First Posted (Estimate)

July 30, 2015

Study Record Updates

Last Update Posted (Estimate)

July 30, 2015

Last Update Submitted That Met QC Criteria

July 27, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • UGF 01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe